(2 references)-
- 抗原 See all SLC6A3 抗体
- SLC6A3 (Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3))
-
适用
- 小鼠, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This SLC6A3 antibody is un-conjugated
-
应用范围
- Immunohistochemistry (IHC)
- 纯化方法
- affinity purified
- Top Product
- Discover our top product SLC6A3 Primary Antibody
-
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (C-Term) antibody
SLC6A3 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (AA 251-350) antibodySLC6A3 适用: 人, 小鼠, 大鼠 WB, ELISA, FACS, IHC (fro), IHC (p), IF (cc), IF (p) 宿主: 兔 Polyclonal unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (AA 1-620) antibodySLC6A3 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (AA 161-237) antibodySLC6A3 适用: 人 WB, ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) antibodySLC6A3 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (N-Term) antibodySLC6A3 适用: 小鼠, 大鼠 WB, ICC, IF 宿主: 小鼠 Monoclonal 6V-23-23 unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (EL2 Region) antibodySLC6A3 适用: 人 WB, IHC, IHC (fro), IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (pThr53) antibodySLC6A3 适用: 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (2nd Extracellular Loop), (AA 191-205) antibodySLC6A3 适用: 小鼠, 大鼠 WB, IHC, ICC, IF, LCI 宿主: 兔 Polyclonal unconjugated
anti-Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3) (AA 562-620) antibodySLC6A3 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator. It is not recommended to use this product in WB. This product is not tested in IP yet. This product is not tested in ICC yet.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- For reconstitution add 200 μL H2O, then aliquot and store at -20 °C until use.
- 缓冲液
- PBS
- 注意事项
- Affinity purified antibodies are less robust than antisera, since protease inhibitors are also removed during purification. Hence, storage at 4 °C for prolonged periods (i.e. several weeks), is not recommended.
- 储存条件
- -20 °C
- 储存方法
- Unlabeled lyophilized antibodies are stable in this form without loss of quality at ambient temperatures for several weeks or even months. They can be stored at 4°C for several years. Lyophilized antibodies must not be stored in the freezer, they may be destroyed!
-
-
: "Enhanced Intracranial Microdialysis by Reduction of Traumatic Penetration Injury at the Probe Track." in: ACS chemical neuroscience, Vol. 7, Issue 6, pp. 728-36, (2016) (PubMed).
: "Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes. ..." in: Nature neuroscience, Vol. 20, Issue 2, pp. 176-188, (2016) (PubMed).
-
: "Enhanced Intracranial Microdialysis by Reduction of Traumatic Penetration Injury at the Probe Track." in: ACS chemical neuroscience, Vol. 7, Issue 6, pp. 728-36, (2016) (PubMed).
-
- 抗原
- SLC6A3 (Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3 (SLC6A3))
- 别名
- DAT (SLC6A3 产品)
- 别名
- DAT antibody, SLC6A3 antibody, Dat1 antibody, DAT1 antibody, PKDYS antibody, solute carrier family 6 member 3 antibody, solute carrier family 6 (neurotransmitter transporter), member 3 antibody, Sodium-dependent dopamine transporter antibody, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 antibody, SLC6A3 antibody, slc6a3 antibody, dat-1 antibody, Slc6a3 antibody
- 背景
- Synonyms: Dopamine transporter, SLC6A3
- 途径
- Dopaminergic Neurogenesis
-
You are here:
